326 related articles for article (PubMed ID: 20233507)
1. In vitro and in vivo characterization of novel biodegradable polymers for application as drug-eluting stent coatings.
Lockwood NA; Hergenrother RW; Patrick LM; Stucke SM; Steendam R; Pacheco E; Virmani R; Kolodgie FD; Hubbard B
J Biomater Sci Polym Ed; 2010; 21(4):529-52. PubMed ID: 20233507
[TBL] [Abstract][Full Text] [Related]
2. A Promising Approach for Improving the Coating Stability and In Vivo Performance of Biodegradable Polymer-Coated Sirolimus-Eluting Stent.
Bedair TM; Kang SN; Joung YK; Han DK
J Biomed Nanotechnol; 2016 Nov; 12(11):2015-28. PubMed ID: 29364616
[TBL] [Abstract][Full Text] [Related]
3. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
Jabara R; Chronos N; Robinson K
Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
[TBL] [Abstract][Full Text] [Related]
4. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
[TBL] [Abstract][Full Text] [Related]
5. Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing.
van der Giessen WJ; Sorop O; Serruys PW; Peters-Krabbendam I; van Beusekom HM
JACC Cardiovasc Interv; 2009 Apr; 2(4):284-90. PubMed ID: 19463438
[TBL] [Abstract][Full Text] [Related]
6. The SYNERGY biodegradable polymer everolimus eluting coronary stent: Porcine vascular compatibility and polymer safety study.
Wilson GJ; Marks A; Berg KJ; Eppihimer M; Sushkova N; Hawley SP; Robertson KA; Knapp D; Pennington DE; Chen YL; Foss A; Huibregtse B; Dawkins KD
Catheter Cardiovasc Interv; 2015 Nov; 86(6):E247-57. PubMed ID: 26009986
[TBL] [Abstract][Full Text] [Related]
7. A Nuclear Magnetic Resonance Spectroscopy as a Method for Evaluation of In Vivo Poly-l-Lactide Biodegradation Kinetics From Stent-Polymer Matrices: An Experimental Study Utilizing Porcine Model of In-Stent Restenosis.
Orlik B; Buszman PP; Krauze A; Gąsior P; Desperak P; Pająk J; Kasperczyk J; Janas A; Jelonek M; Handzlik-Orlik G; Buszman PE; Milewski K
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):93-9. PubMed ID: 25944843
[TBL] [Abstract][Full Text] [Related]
8. The Supralimus sirolimus-eluting stent.
Lemos PA; Bienert I
Expert Rev Med Devices; 2013 May; 10(3):295-300. PubMed ID: 23597097
[TBL] [Abstract][Full Text] [Related]
9. Surface Modification of Biodegradable Polymers towards Better Biocompatibility and Lower Thrombogenicity.
Rudolph A; Teske M; Illner S; Kiefel V; Sternberg K; Grabow N; Wree A; Hovakimyan M
PLoS One; 2015; 10(12):e0142075. PubMed ID: 26641662
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix.
Granada JF; Inami S; Aboodi MS; Tellez A; Milewski K; Wallace-Bradley D; Parker S; Rowland S; Nakazawa G; Vorpahl M; Kolodgie FD; Kaluza GL; Leon MB; Virmani R
Circ Cardiovasc Interv; 2010 Jun; 3(3):257-66. PubMed ID: 20442358
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent.
Udipi K; Chen M; Cheng P; Jiang K; Judd D; Caceres A; Melder RJ; Wilcox JN
J Biomed Mater Res A; 2008 Jun; 85(4):1064-71. PubMed ID: 17937416
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo performance of a dual drug-eluting stent (DDES).
Huang Y; Venkatraman SS; Boey FY; Lahti EM; Umashankar PR; Mohanty M; Arumugam S; Khanolkar L; Vaishnav S
Biomaterials; 2010 May; 31(15):4382-91. PubMed ID: 20189244
[TBL] [Abstract][Full Text] [Related]
13. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
14. Optimized polymer coating for magnesium alloy-based bioresorbable scaffolds for long-lasting drug release and corrosion resistance.
Xu W; Yagoshi K; Koga Y; Sasaki M; Niidome T
Colloids Surf B Biointerfaces; 2018 Mar; 163():100-106. PubMed ID: 29284158
[TBL] [Abstract][Full Text] [Related]
15. The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts.
Steigerwald K; Merl S; Kastrati A; Wieczorek A; Vorpahl M; Mannhold R; Vogeser M; Hausleiter J; Joner M; Schömig A; Wessely R
Biomaterials; 2009 Feb; 30(4):632-7. PubMed ID: 18990438
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterisation of biodegradable polymer-based drug-eluting stent.
Yazdani SK; Vorpahl M; Nakano M; Su SH; Kolodgie FD; Virmani R
EuroIntervention; 2011 Nov; 7(7):835-43. PubMed ID: 22082579
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
[TBL] [Abstract][Full Text] [Related]
19. Investigation of long-term implantation of BuMA stent in a porcine coronary model.
Chen M; Wang XG; Zheng B; Peng HY; Zhang XY; Zhang B; Huo Y
Chin Med J (Engl); 2012 Nov; 125(22):4083-7. PubMed ID: 23158147
[TBL] [Abstract][Full Text] [Related]
20. Dual drug-eluting stents coated with multilayers of hydrophobic heparin and sirolimus.
Su LC; Chen YH; Chen MC
ACS Appl Mater Interfaces; 2013 Dec; 5(24):12944-53. PubMed ID: 24294944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
